[1]
2022. Evaluation Of Azilsartan Transdermal Hydrogel In Volumetric Muscle Loss Injury In A Rat Model. Journal of Pharmaceutical Negative Results. 13, (Nov. 2022), 2517–2522. DOI:https://doi.org/10.47750/pnr.2022.13.S05.389.